EP 0868430 A1 19981007 - THERAPEUTIC COMPOSITIONS
Title (en)
THERAPEUTIC COMPOSITIONS
Title (de)
THERAPEUTISCHE ZUSAMMENSETZUNGEN
Title (fr)
COMPOSITIONS THERAPEUTIQUES
Publication
Application
Priority
- AU 9600827 W 19961220
- AU PN727595 A 19951222
Abstract (en)
[origin: WO9723501A1] The present invention relates generally to molecules capable of modulating apoptosis of animal cells. More particularly, the present invention provides cell homologues of viral-derived, apoptotic-inhibiting molecules which are useful in modulating apoptosis of animal cells. The molecules contemplated by the present invention may be used to promote or inhibit cell apoptosis depending on the exigencies of the therapeutic situation.
IPC 1-7
IPC 8 full level
A61K 31/00 (2006.01); A61K 31/16 (2006.01); A61K 38/00 (2006.01); A61P 31/00 (2006.01); A61P 35/00 (2006.01); A61P 37/00 (2006.01); A61P 37/02 (2006.01); A61P 43/00 (2006.01); C07K 14/005 (2006.01); C07K 14/39 (2006.01); C07K 14/435 (2006.01); C07K 14/47 (2006.01); C12N 15/09 (2006.01)
CPC (source: EP)
A61P 31/00 (2017.12); A61P 35/00 (2017.12); A61P 37/00 (2017.12); A61P 37/02 (2017.12); A61P 43/00 (2017.12); C07K 14/4747 (2013.01); A61K 38/00 (2013.01)
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9723501 A1 19970703; AU 1089197 A 19970717; AU 710221 B2 19990916; AU PN727595 A0 19960118; CA 2241129 A1 19970703; EP 0868430 A1 19981007; EP 0868430 A4 20020807; JP 2000504932 A 20000425
DOCDB simple family (application)
AU 9600827 W 19961220; AU 1089197 A 19961220; AU PN727595 A 19951222; CA 2241129 A 19961220; EP 96941537 A 19961220; JP 52315797 A 19961220